For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life.

Since 1995, the American Academy of Neurology has provided guidelines for brain death determination, but nationwide adherence to these guidelines has been incomplete.

Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy.

Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements.

Dr Ariane Lewis discusses how we can navigate uncertainty and ambiguity about brain death by understanding clinical criteria for brain death determination and how our approaches to death are culturally and socially situated.

More cesarean deliveries among Black and Hispanic women in the United States has long demonstrated racial inequity in obstetrical care.

Heightened privacy and confidentiality stakes generate unique anonymity and nondisclosure policies and practices for HIV.

This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing.

Patients writing daily journal briefs about work-related activities and pain can help clinicians help them.

Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives.